{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T05:17:25Z","timestamp":1740633445584,"version":"3.38.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100006396","name":"Qazvin University of Medical Sciences","doi-asserted-by":"publisher","award":["400000629"],"award-info":[{"award-number":["400000629"]}],"id":[{"id":"10.13039\/501100006396","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diagnostic Microbiology and Infectious Disease"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.diagmicrobio.2024.116628","type":"journal-article","created":{"date-parts":[[2024,11,26]],"date-time":"2024-11-26T07:51:08Z","timestamp":1732607468000},"page":"116628","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Overexpression of PIN1 in patients with severe COVID-19"],"prefix":"10.1016","volume":"111","author":[{"given":"Hajie","family":"Lotfi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farnaz","family":"Vafanezad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiva","family":"Ansari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zahra","family":"Rashvand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hamid","family":"Sadeghi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sahar","family":"Moghbelinejad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saeideh Gholamzadeh","family":"Khoei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nematollah","family":"Gheibi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.diagmicrobio.2024.116628_bib0001","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1125246","article-title":"The development of COVID-19 treatment","volume":"14","author":"Yuan","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.diagmicrobio.2024.116628_bib0002","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2020.145145","article-title":"Serum CCL17 level becomes a predictive marker to distinguish between mild\/moderate and severe\/critical disease in patients with COVID-19","volume":"766","author":"Sugiyama","year":"2021","journal-title":"Gene"},{"issue":"39","key":"10.1016\/j.diagmicrobio.2024.116628_bib0003","doi-asserted-by":"crossref","first-page":"e34675","DOI":"10.1097\/MD.0000000000034675","article-title":"GDF-15 (a biomarker for metformin) and the risk of COVID-19: a two-sample mendelian randomization study","volume":"102","author":"Wang","year":"2023","journal-title":"Medicine"},{"key":"10.1016\/j.diagmicrobio.2024.116628_bib0004","doi-asserted-by":"crossref","first-page":"94","DOI":"10.3389\/fonc.2019.00094","article-title":"Oncogenic hijacking of the PIN1 signaling network","volume":"9","author":"Zannini","year":"2019","journal-title":"Front Oncol"},{"key":"10.1016\/j.diagmicrobio.2024.116628_bib0005","first-page":"1","article-title":"Impact of PIN1 inhibition on tumor progression and chemotherapy sensitivity in colorectal cancer","author":"S","year":"2022","journal-title":"J Gastrointest Cancer"},{"key":"10.1016\/j.diagmicrobio.2024.116628_bib0006","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.3389\/fphar.2018.01367","article-title":"PIN1 in cell cycle control and cancer","volume":"9","author":"Cheng","year":"2018","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.diagmicrobio.2024.116628_bib0007","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1007\/s12094-019-02233-5","article-title":"Prognostic value of peptidyl-prolyl cis\u2013trans isomerase 1 (PIN1) in human malignant tumors","volume":"22","author":"Khoei","year":"2020","journal-title":"Clin Transl Oncol"},{"key":"10.1016\/j.diagmicrobio.2024.116628_bib0008","doi-asserted-by":"crossref","unstructured":"Li J., Mo C., Guo Y., Zhang B., Feng X., Si Q., et al. Roles of peptidyl-prolyl isomerase PIN1 in disease pathogenesis. 2021;11(7):3348.","DOI":"10.7150\/thno.45889"},{"key":"10.1016\/j.diagmicrobio.2024.116628_bib0009","doi-asserted-by":"crossref","unstructured":"Kanna M., Nakatsu Y., Yamamotoya T., Encinas J., Ito H., Okabe T., et al. Roles of peptidyl prolyl isomerase PIN1 in viral propagation. 2022;10:1005325.","DOI":"10.3389\/fcell.2022.1005325"},{"key":"10.1016\/j.diagmicrobio.2024.116628_bib0010","doi-asserted-by":"crossref","unstructured":"Yamamotoya T., Nakatsu Y., Kanna M., Hasei S., Ohata Y., Encinas J., et al. Prolyl isomerase PIN1 plays an essential role in SARS-CoV-2 proliferation, indicating its possibility as a novel therapeutic target. 2021;11(1):18581.","DOI":"10.1038\/s41598-021-97972-3"},{"key":"10.1016\/j.diagmicrobio.2024.116628_bib0011","doi-asserted-by":"crossref","unstructured":"Sugiyama M., Kinoshita N., Ide S., Nomoto H., Nakamoto T., Saito S., et al. Serum CCL17 level becomes a predictive marker to distinguish between mild\/moderate and severe\/critical disease in patients with COVID-19. 2021;766:145145.","DOI":"10.1016\/j.gene.2020.145145"},{"key":"10.1016\/j.diagmicrobio.2024.116628_bib0012","doi-asserted-by":"crossref","first-page":"e54355","DOI":"10.2196\/54355","article-title":"Addressing hospital overwhelm during the COVID-19 pandemic by using a primary health care-based integrated health system: modeling study","volume":"12","author":"Huang","year":"2024","journal-title":"JMIR Med Inform"},{"key":"10.1016\/j.diagmicrobio.2024.116628_bib0013","doi-asserted-by":"crossref","unstructured":"Wang S.C., Hu X.M., Xiong K. The regulatory role of PIN1 in neuronal death. 2023;18(1):74-80.","DOI":"10.4103\/1673-5374.341043"},{"key":"10.1016\/j.diagmicrobio.2024.116628_bib0014","doi-asserted-by":"crossref","unstructured":"Zhou X.Z., Lu K. The isomerase PIN1 controls numerous cancer-driving pathways and is a unique drug target. 2016;16(7):463-78.","DOI":"10.1038\/nrc.2016.49"},{"issue":"9","key":"10.1016\/j.diagmicrobio.2024.116628_bib0015","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1038\/cr.2014.109","article-title":"Prolyl isomerase PIN1 in cancer","volume":"24","author":"Lu","year":"2014","journal-title":"Cell Res"},{"issue":"5","key":"10.1016\/j.diagmicrobio.2024.116628_bib0016","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S2213-2600(21)00125-9","article-title":"Confronting COVID-19-associated cough and the post-COVID syndrome: role of viral neurotropism, neuroinflammation, and neuroimmune responses","volume":"9","author":"Song","year":"2021","journal-title":"Lancet Respir Med"},{"issue":"10","key":"10.1016\/j.diagmicrobio.2024.116628_bib0017","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1159\/000517400","article-title":"Breathlessness and COVID-19: a call for research","volume":"100","author":"Hentsch","year":"2021","journal-title":"Respiration"},{"issue":"4","key":"10.1016\/j.diagmicrobio.2024.116628_bib0018","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.jinf.2020.05.013","article-title":"Dyspnea rather than fever is a risk factor for predicting mortality in patients with COVID-19","volume":"81","author":"Shi","year":"2020","journal-title":"J Infect"},{"issue":"10223","key":"10.1016\/j.diagmicrobio.2024.116628_bib0019","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.diagmicrobio.2024.116628_bib0020","doi-asserted-by":"crossref","unstructured":"Dochi T., Nakano T., Inoue M., Takamune N., Shoji S., Sano K., et al. Phosphorylation of human immunodeficiency virus type 1 capsid protein at serine 16, required for peptidyl-prolyl isomerase-dependent uncoating, is mediated by virion-incorporated extracellular signal-regulated kinase 2. 2014;95(5):1156-66.","DOI":"10.1099\/vir.0.060053-0"},{"key":"10.1016\/j.diagmicrobio.2024.116628_bib0021","doi-asserted-by":"crossref","unstructured":"Nishi M., Miyakawa K., Matsunaga S., Khatun H., Yamaoka Y., Watashi K., et al. Prolyl isomerase PIN1 regulates the stability of hepatitis B virus core protein. 2020;8:26.","DOI":"10.3389\/fcell.2020.00026"},{"key":"10.1016\/j.diagmicrobio.2024.116628_bib0022","doi-asserted-by":"crossref","unstructured":"Noroozi R., Branicki W., Pyrc K., \u0141abaj P.P., Pospiech E., Taheri M., et al. Altered cytokine levels and immune responses in patients with SARS-CoV-2 infection and related conditions. 2020;133:155143.","DOI":"10.1016\/j.cyto.2020.155143"},{"key":"10.1016\/j.diagmicrobio.2024.116628_bib0023","doi-asserted-by":"crossref","unstructured":"Bi X., Su Z., Yan H., Du J., Wang J., Chen L., et al. Prediction of severe illness due to COVID-19 based on an analysis of initial fibrinogen to albumin ratio and platelet count. 2020;31(5):674-9.","DOI":"10.1080\/09537104.2020.1760230"},{"key":"10.1016\/j.diagmicrobio.2024.116628_bib0024","doi-asserted-by":"crossref","unstructured":"Petrilli C.M., Jones S.A., Yang J., Rajagopalan H., O'Donnell L., Chernyak Y., et al. Factors associated with hospital admission and critical illness among 5279 people with Coronavirus disease 2019 in New York City: prospective cohort study. 2020;369.","DOI":"10.1136\/bmj.m1966"},{"key":"10.1016\/j.diagmicrobio.2024.116628_bib0025","doi-asserted-by":"crossref","unstructured":"Sciacchitano S., Sacconi A., De Vitis C., Blandino G., Piaggio G., Salvati V., et al. H-Ras gene takes part to the host immune response to COVID-19. 2021;7(1):158.","DOI":"10.1038\/s41420-021-00541-w"}],"container-title":["Diagnostic Microbiology and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889324004528?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889324004528?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T09:00:15Z","timestamp":1740560415000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0732889324004528"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S0732889324004528"],"URL":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2024.116628","relation":{},"ISSN":["0732-8893"],"issn-type":[{"type":"print","value":"0732-8893"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Overexpression of PIN1 in patients with severe COVID-19","name":"articletitle","label":"Article Title"},{"value":"Diagnostic Microbiology and Infectious Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2024.116628","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"116628"}}